These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 33187137

  • 21. The Therapeutic Potential of Targeting NIK in B Cell Malignancies.
    Haselager MV, Eldering E.
    Front Immunol; 2022; 13():930986. PubMed ID: 35911754
    [Abstract] [Full Text] [Related]

  • 22. A Kinase Assay for Measuring the Activity of the NIK-IKK1 Complex Induced via the Noncanonical NF-κB Pathway.
    Mukherjee T, Ratra Y, Banoth B, Deka A, Polley S, Basak S.
    Methods Mol Biol; 2021; 2366():165-181. PubMed ID: 34236638
    [Abstract] [Full Text] [Related]

  • 23. NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis.
    Noort AR, van Zoest KP, Weijers EM, Koolwijk P, Maracle CX, Novack DV, Siemerink MJ, Schlingemann RO, Tak PP, Tas SW.
    J Pathol; 2014 Nov; 234(3):375-85. PubMed ID: 25043127
    [Abstract] [Full Text] [Related]

  • 24. Carboxyl terminus of HSC70-interacting protein (CHIP) down-regulates NF-κB-inducing kinase (NIK) and suppresses NIK-induced liver injury.
    Jiang B, Shen H, Chen Z, Yin L, Zan L, Rui L.
    J Biol Chem; 2015 May 01; 290(18):11704-14. PubMed ID: 25792747
    [Abstract] [Full Text] [Related]

  • 25. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
    Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K.
    Nature; 1999 Mar 18; 398(6724):252-6. PubMed ID: 10094049
    [Abstract] [Full Text] [Related]

  • 26. Analysis of the binding pattern of NIK inhibitors by computational simulation.
    Tang Y.
    J Biomol Struct Dyn; 2024 Apr 18; 42(7):3318-3331. PubMed ID: 37183664
    [Abstract] [Full Text] [Related]

  • 27. NIK and IKKbeta interdependence in NF-kappaB signalling--flux analysis of regulation through metabolites.
    Kim HB, Evans I, Smallwood R, Holcombe M, Qwarnstrom EE.
    Biosystems; 2010 Feb 18; 99(2):140-9. PubMed ID: 19909783
    [Abstract] [Full Text] [Related]

  • 28. The RET/PTC3 oncogene activates classical NF-κB by stabilizing NIK.
    Neely RJ, Brose MS, Gray CM, McCorkell KA, Leibowitz JM, Ma C, Rothstein JL, May MJ.
    Oncogene; 2011 Jan 06; 30(1):87-96. PubMed ID: 20818435
    [Abstract] [Full Text] [Related]

  • 29. Glucocorticoid receptor signaling contributes to constitutive activation of the noncanonical NF-κB pathway in term human placenta.
    Wang B, Palomares K, Parobchak N, Cece J, Rosen M, Nguyen A, Rosen T.
    Mol Endocrinol; 2013 Feb 06; 27(2):203-11. PubMed ID: 23239753
    [Abstract] [Full Text] [Related]

  • 30. Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells.
    Saitoh Y, Martínez Bruyn VJ, Uota S, Hasegawa A, Yamamoto N, Imoto I, Inazawa J, Yamaoka S.
    Lung Cancer; 2010 Dec 06; 70(3):263-70. PubMed ID: 20338663
    [Abstract] [Full Text] [Related]

  • 31. Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses.
    Li Y, Wang H, Zhou X, Xie X, Chen X, Jie Z, Zou Q, Hu H, Zhu L, Cheng X, Brightbill HD, Wu LC, Wang L, Sun SC.
    Sci Rep; 2016 Feb 25; 6():22115. PubMed ID: 26912039
    [Abstract] [Full Text] [Related]

  • 32. SM22α suppresses cytokine-induced inflammation and the transcription of NF-κB inducing kinase (Nik) by modulating SRF transcriptional activity in vascular smooth muscle cells.
    Dai X, Thiagarajan D, Fang J, Shen J, Annam NP, Yang Z, Jiang H, Ju D, Xie Y, Zhang K, Tseng YY, Yang Z, Rishi AK, Li HJ, Yang M, Li L.
    PLoS One; 2017 Feb 25; 12(12):e0190191. PubMed ID: 29284006
    [Abstract] [Full Text] [Related]

  • 33. NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway.
    Thu YM, Su Y, Yang J, Splittgerber R, Na S, Boyd A, Mosse C, Simons C, Richmond A.
    Oncogene; 2012 May 17; 31(20):2580-92. PubMed ID: 21963849
    [Abstract] [Full Text] [Related]

  • 34. Molecular determinants of NF-kappaB-inducing kinase action.
    Lin X, Mu Y, Cunningham ET, Marcu KB, Geleziunas R, Greene WC.
    Mol Cell Biol; 1998 Oct 17; 18(10):5899-907. PubMed ID: 9742107
    [Abstract] [Full Text] [Related]

  • 35. The NF-kappaB pathway in human endometrium and first trimester decidua.
    King AE, Critchley HO, Kelly RW.
    Mol Hum Reprod; 2001 Feb 17; 7(2):175-83. PubMed ID: 11160844
    [Abstract] [Full Text] [Related]

  • 36. NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes.
    Xiao P, Takiishi T, Violato NM, Licata G, Dotta F, Sebastiani G, Marselli L, Singh SP, Sze M, Van Loo G, Dejardin E, Gurzov EN, Cardozo AK.
    Cell Death Dis; 2022 May 19; 13(5):476. PubMed ID: 35589698
    [Abstract] [Full Text] [Related]

  • 37. Transcriptional induction of NF-κB-inducing kinase by E2F4/5 facilitates collective invasion of GBM cells.
    Pflug KM, Lee DW, McFadden K, Herrera L, Sitcheran R.
    Sci Rep; 2023 Aug 11; 13(1):13093. PubMed ID: 37567906
    [Abstract] [Full Text] [Related]

  • 38. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.
    Rosebeck S, Madden L, Jin X, Gu S, Apel IJ, Appert A, Hamoudi RA, Noels H, Sagaert X, Van Loo P, Baens M, Du MQ, Lucas PC, McAllister-Lucas LM.
    Science; 2011 Jan 28; 331(6016):468-72. PubMed ID: 21273489
    [Abstract] [Full Text] [Related]

  • 39. NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.
    Odqvist L, Sánchez-Beato M, Montes-Moreno S, Martín-Sánchez E, Pajares R, Sánchez-Verde L, Ortiz-Romero PL, Rodriguez J, Rodríguez-Pinilla SM, Iniesta-Martínez F, Solera-Arroyo JC, Ramos-Asensio R, Flores T, Palanca JM, Bragado FG, Franjo PD, Piris MA.
    Clin Cancer Res; 2013 May 01; 19(9):2319-30. PubMed ID: 23536439
    [Abstract] [Full Text] [Related]

  • 40. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A, Kaisho T, Rennert PD, Nakano H, Kurosawa K, Uchida D, Takeda K, Akira S, Matsumoto M.
    J Exp Med; 2001 Mar 05; 193(5):631-6. PubMed ID: 11238593
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.